Recce Pharmaceuticals Ltd R9Q.F Stock
Recce Pharmaceuticals Ltd Price Chart
Recce Pharmaceuticals Ltd R9Q.F Financial and Trading Overview
| Recce Pharmaceuticals Ltd stock price | 0.31 EUR |
| Previous Close | 0.32 EUR |
| Open | 0.34 EUR |
| Bid | 0.34 EUR x N/A |
| Ask | 0.35 EUR x N/A |
| Day's Range | 0.34 - 0.34 EUR |
| 52 Week Range | 0.32 - 0.63 EUR |
| Volume | 2.95K EUR |
| Avg. Volume | 52 EUR |
| Market Cap | 60.61M EUR |
| Beta (5Y Monthly) | 1.106896 |
| PE Ratio (TTM) | N/A |
| EPS (TTM) | -0.04 EUR |
| Forward Dividend & Yield | N/A (N/A) |
| Ex-Dividend Date | N/A |
| 1y Target Est | N/A |
R9Q.F Valuation Measures
| Enterprise Value | 59.89M EUR |
| Trailing P/E | N/A |
| Forward P/E | N/A |
| PEG Ratio (5 yr expected) | N/A |
| Price/Sales (ttm) | 19.645784 |
| Price/Book (mrq) | 48.571426 |
| Enterprise Value/Revenue | 19.415 |
| Enterprise Value/EBITDA | -3.921 |
Trading Information
Recce Pharmaceuticals Ltd Stock Price History
| Beta (5Y Monthly) | 1.106896 |
| 52-Week Change | -12.62% |
| S&P500 52-Week Change | 20.43% |
| 52 Week High | 0.63 EUR |
| 52 Week Low | 0.32 EUR |
| 50-Day Moving Average | 0.36 EUR |
| 200-Day Moving Average | 0.41 EUR |
R9Q.F Share Statistics
| Avg. Volume (3 month) | 52 EUR |
| Avg. Daily Volume (10-Days) | 0 EUR |
| Shares Outstanding | 178.25M |
| Float | 106.88M |
| Short Ratio | N/A |
| % Held by Insiders | 42.50% |
| % Held by Institutions | 3.05% |
| Shares Short | N/A |
| Short % of Float | N/A |
| Short % of Shares Outstanding | N/A |
Dividends & Splits
| Trailing Annual Dividend Rate | 0 |
| Trailing Annual Dividend Yield | 0% |
| 5 Year Average Dividend Yield | N/A |
| Payout Ratio | 0 |
| Last Split Factor |
Financial Highlights
Fiscal Year
| Fiscal Year Ends | June 30, 2022 |
| Most Recent Quarter (mrq) | December 31, 2022 |
| Next Fiscal Year End | June 30, 2023 |
Profitability
| Profit Margin | 0% |
| Operating Margin (ttm) | -495.64% |
| Gross Margin | -161.50% |
| EBITDA Margin | 0% |
Management Effectiveness
| Return on Assets (ttm) | -98.52% |
| Return on Equity (ttm) | -181.71% |
Income Statement
| Revenue (ttm) | 3.08M EUR |
| Revenue Per Share (ttm) | 0.02 EUR |
| Quarterly Revenue Growth (yoy) | -63.60% |
| Gross Profit (ttm) | -3245992 EUR |
| EBITDA | -15274781 EUR |
| Net Income Avi to Common (ttm) | -15225219 EUR |
| Diluted EPS (ttm) | -0.05 |
| Quarterly Earnings Growth (yoy) | N/A |
Balance Sheet
| Total Cash (mrq) | 1.85M EUR |
| Total Cash Per Share (mrq) | 0.01 EUR |
| Total Debt (mrq) | 127.46K EUR |
| Total Debt/Equity (mrq) | 10.3 EUR |
| Current Ratio (mrq) | 1.85 |
| Book Value Per Share (mrq) | 0.007 |
Cash Flow Statement
| Operating Cash Flow (ttm) | -14466550 EUR |
| Levered Free Cash Flow (ttm) | -8628034 EUR |
Profile of Recce Pharmaceuticals Ltd
| Country | Germany |
| State | NSW |
| City | Sydney |
| Address | Aurora Place |
| ZIP | 2000 |
| Phone | 61 2 9256 2571 |
| Website | https://www.recce.com.au |
| Industry | Biotechnology |
| Sector(s) | Healthcare |
| Full Time Employees | N/A |
Recce Pharmaceuticals Ltd, a biotechnology company, engages in the research, development, and commercialization of synthetic antiinfectives in Australia, the United States, and the United Kingdom. The company's lead candidate is RECCE 327 to treat blood infections and sepsis derived from E. coli and S. aureus bacteria, including their superbug forms. It also develops RECCE 529, a synthetic anti-infective for viral infections; and RECCE 435, a synthetic polymer anti-infective. The company was formerly known as Recce Limited and changed its name to Recce Pharmaceuticals Ltd in November 2017. Recce Pharmaceuticals Ltd was incorporated in 2007 and is headquartered in Sydney, Australia.
Q&A For Recce Pharmaceuticals Ltd Stock
What is a current R9Q.F stock price?
Recce Pharmaceuticals Ltd R9Q.F stock price today per share is 0.31 EUR.
How to purchase Recce Pharmaceuticals Ltd stock?
You can buy R9Q.F shares on the Frankfurt exchange. Contact your financial advisor to select a broker.
What is the ticker symbol for Recce Pharmaceuticals Ltd?
The stock symbol or ticker of Recce Pharmaceuticals Ltd is R9Q.F.
Which industry does the Recce Pharmaceuticals Ltd company belong to?
The Recce Pharmaceuticals Ltd industry is Biotechnology.
How many shares does Recce Pharmaceuticals Ltd have in circulation?
The max supply of Recce Pharmaceuticals Ltd shares is 232.39M.
What is Recce Pharmaceuticals Ltd Price to Earnings Ratio (PE Ratio)?
Recce Pharmaceuticals Ltd PE Ratio is now.
What was Recce Pharmaceuticals Ltd earnings per share over the trailing 12 months (TTM)?
Recce Pharmaceuticals Ltd EPS is -0.04 EUR over the trailing 12 months.
Which sector does the Recce Pharmaceuticals Ltd company belong to?
The Recce Pharmaceuticals Ltd sector is Healthcare.